Ramelteon is the first in a new class of sleep agents that selectively binds to the melatonin receptors in the suprachiasmatic nucleus (SCN). It is used for insomnia, particularly delayed sleep onset. Ramelteon has not been shown to produce dependence and has shown no potential for abuse.
用于失眠症,特别适用于治疗难以入睡型失眠症。
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.